Whitehawk Therapeutics (WHWK) Competitors $2.02 -0.15 (-6.91%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock WHWK vs. DMAC, LBRX, RCKT, CGEM, CGC, ENGN, UPXI, AMRN, ANNX, and ACBShould you be buying Whitehawk Therapeutics stock or one of its competitors? The main competitors of Whitehawk Therapeutics include DiaMedica Therapeutics (DMAC), LB Pharmaceuticals (LBRX), Rocket Pharmaceuticals (RCKT), Cullinan Therapeutics (CGEM), Canopy Growth (CGC), enGene (ENGN), Upexi (UPXI), Amarin (AMRN), Annexon (ANNX), and Aurora Cannabis (ACB). These companies are all part of the "pharmaceutical products" industry. Whitehawk Therapeutics vs. Its Competitors DiaMedica Therapeutics LB Pharmaceuticals Rocket Pharmaceuticals Cullinan Therapeutics Canopy Growth enGene Upexi Amarin Annexon Aurora Cannabis Whitehawk Therapeutics (NASDAQ:WHWK) and DiaMedica Therapeutics (NASDAQ:DMAC) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Is WHWK or DMAC more profitable? Whitehawk Therapeutics has a net margin of 99.42% compared to DiaMedica Therapeutics' net margin of 0.00%. Whitehawk Therapeutics' return on equity of -75.99% beat DiaMedica Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Whitehawk Therapeutics99.42% -75.99% -68.57% DiaMedica Therapeutics N/A -78.99%-69.94% Which has more volatility and risk, WHWK or DMAC? Whitehawk Therapeutics has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Comparatively, DiaMedica Therapeutics has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Does the media prefer WHWK or DMAC? In the previous week, Whitehawk Therapeutics had 1 more articles in the media than DiaMedica Therapeutics. MarketBeat recorded 5 mentions for Whitehawk Therapeutics and 4 mentions for DiaMedica Therapeutics. Whitehawk Therapeutics' average media sentiment score of 1.10 beat DiaMedica Therapeutics' score of 0.62 indicating that Whitehawk Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Whitehawk Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DiaMedica Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in WHWK or DMAC? 52.1% of Whitehawk Therapeutics shares are owned by institutional investors. Comparatively, 10.1% of DiaMedica Therapeutics shares are owned by institutional investors. 49.9% of Whitehawk Therapeutics shares are owned by company insiders. Comparatively, 7.3% of DiaMedica Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has better valuation & earnings, WHWK or DMAC? DiaMedica Therapeutics has lower revenue, but higher earnings than Whitehawk Therapeutics. Whitehawk Therapeutics is trading at a lower price-to-earnings ratio than DiaMedica Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWhitehawk Therapeutics$25.98M3.66-$63.69M-$0.06-33.67DiaMedica TherapeuticsN/AN/A-$24.44M-$0.69-9.62 Do analysts prefer WHWK or DMAC? DiaMedica Therapeutics has a consensus price target of $12.33, indicating a potential upside of 85.74%. Given DiaMedica Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe DiaMedica Therapeutics is more favorable than Whitehawk Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Whitehawk Therapeutics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50DiaMedica Therapeutics 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryWhitehawk Therapeutics beats DiaMedica Therapeutics on 9 of the 15 factors compared between the two stocks. Get Whitehawk Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WHWK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WHWK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WHWK vs. The Competition Export to ExcelMetricWhitehawk TherapeuticsPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$95.20M$1.03B$2.48B$10.24BDividend YieldN/A4.84%2.47%4.69%P/E Ratio-33.671.3026.2126.57Price / Sales3.6630.60115.86179.21Price / CashN/A17.6448.4562.20Price / Book0.957.3137.426.53Net Income-$63.69M-$7.96M$6.99M$275.96M7 Day Performance3.06%30.42%-1.84%-1.40%1 Month Performance12.85%27.56%0.95%5.16%1 Year PerformanceN/A-6.52%69.55%31.55% Whitehawk Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WHWKWhitehawk Therapeutics1.0122 of 5 stars$2.02-6.9%N/AN/A$95.20M$25.98M-33.6721News CoveragePositive NewsAnalyst UpgradeDMACDiaMedica Therapeutics2.0805 of 5 stars$6.86-0.1%$12.33+79.8%+56.0%$355.10MN/A-9.9420Positive NewsAnalyst ForecastLBRXLB PharmaceuticalsN/A$15.76-0.2%N/AN/A$354.38MN/A0.0016News CoverageAnalyst UpgradeAnalyst RevisionRCKTRocket Pharmaceuticals4.7385 of 5 stars$3.16-3.1%$16.73+429.5%-77.9%$351.77MN/A-1.26240Analyst ForecastCGEMCullinan Therapeutics2.4648 of 5 stars$6.00+1.2%$26.00+333.3%-54.4%$350.31MN/A-1.8630Analyst ForecastCGCCanopy Growth0.9227 of 5 stars$1.38-5.5%N/A-59.1%$350.18M$225.65M-0.463,150Analyst ForecastOptions VolumeENGNenGene2.7859 of 5 stars$7.60+11.3%$19.50+156.6%+28.5%$349.64MN/A-4.0031UPXIUpexi2.6621 of 5 stars$6.53+13.2%$15.50+137.4%+184.2%$339.79M$15.81M0.00130Positive NewsAMRNAmarin0.4641 of 5 stars$16.64+1.6%$12.00-27.9%+64.4%$338.78M$228.61M-4.53360Trending NewsAnalyst ForecastAnalyst RevisionANNXAnnexon2.8696 of 5 stars$3.03-0.7%$12.50+312.5%-53.1%$335.15MN/A-2.3560Positive NewsAnalyst ForecastACBAurora Cannabis0.4878 of 5 stars$5.73-3.9%N/A+15.4%$335.08M$246.72M-30.161,130Analyst Forecast Related Companies and Tools Related Companies DMAC Competitors LBRX Competitors RCKT Competitors CGEM Competitors CGC Competitors ENGN Competitors UPXI Competitors AMRN Competitors ANNX Competitors ACB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WHWK) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Whitehawk Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Whitehawk Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
